Addex Therapeutics ADXN
NASDAQ ADXN
$3.07 +0.09 (+3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Addex Therapeutics' Return on Capital Employed [ROCE] came in at -93.18% for Q2 2026, down 33.08 percentage points from -60.10% a year earlier and down 31.94 percentage points from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Addex Therapeutics' Return on Capital Employed [ROCE] was -41.19%, down 0.90 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +15.61 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -40.29% in FY2024 (+28.93 pp), -69.22% in FY2023 (+14.21 pp), -83.43% in FY2022 (+5.54 pp) and -88.97% in FY2021 (-32.17 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of +120.66 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 604.45 percentage points), and the weakest in Q1 2023 (a drop of 513.61 percentage points).
  • Business Quant data shows ADXN's Return on Capital Employed [ROCE] at -61.24% (Q1 2026), -48.20% (Q4 2025) and -67.57% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Addex Therapeutics 2.75 Mn 2.75 Mn - -93.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -93.18%
Mar 31, 2026 -61.24%
Dec 31, 2025 -48.20%
Sep 30, 2025 -67.57%
Jun 30, 2025 -60.10%
Mar 31, 2025 -54.27%
Dec 31, 2024 -47.21%
Sep 30, 2024 -37.90%
Jun 30, 2024 -62.48%
Mar 31, 2024 -658.71%
Dec 31, 2023 -148.99%
Sep 30, 2023 -365.31%
Jun 30, 2023 -446.17%
Mar 31, 2023 -695.91%
Dec 31, 2022 -542.49%
Sep 30, 2022 -435.72%
Jun 30, 2022 -311.35%
Mar 31, 2022 -182.30%
Dec 31, 2021 -165.78%
Sep 30, 2021 -143.05%
API Access

Addex Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ADXN&period=max&api_key=YOUR_API_KEY